Steven Cohen Alvotech Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Alvotech stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 11,700 shares of ALVO stock, worth $142,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,700Holding current value
$142,272% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALVO
# of Institutions
24Shares Held
14.3MCall Options Held
100KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA3.13MShares$38 Million0.0% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca2.9MShares$35.3 Million0.68% of portfolio
-
Bracebridge Capital, LLC2.71MShares$32.9 Million35.14% of portfolio
-
Sculptor Capital LP New York, NY1.95MShares$23.7 Million0.76% of portfolio
-
Littlejohn & CO LLC1.22MShares$14.8 Million7.72% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $3.02B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...